Kaposi’s sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells

mBio

Volumn 5, Issue 6, 2014, Pages

  Jha, Hem C ^a   Lu, Jie ^a   Verma, Subhash C ^b   Banerjee, Shuvomoy ^a   Mehta, Devan ^a   Robertson, Erle S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; MESSENGER RNA; PROTEIN K8; PROTEIN LANA; PROTEIN RTA; UNCLASSIFIED DRUG; VIRUS PROTEIN; HISTONE; PROTEIN BINDING; VIRAL PROTEIN;

ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; HERPES VIRUS INFECTION; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; K3 GENE; LYSIS; NONHUMAN; ORF49 GENE; ORF64 GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BINDING; VIRUS GENE; VIRUS GENOME; ACETYLATION; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; METABOLISM; METHYLATION; MONONUCLEAR CELL; PROTEIN PROCESSING; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

ACETYLATION; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HISTONES; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; METHYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; VIRAL PROTEINS;

EID: 84920983161     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02261-14     Document Type: Article

References (61)

1. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186–1191. http://dx.doi.org/10.1056/NEJM199505043321802.
2. Moore PS, Chang Y. 1995. Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma in patients with and without HIV infection. N. Engl. J. Med. 332:1181–1185. http://dx.doi.org/10.1056/NEJM199505043321801.
3. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d’Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. 1995. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86:1276–1280.
4. Rettig MB, Ma HJ, Vescio RA, Põld M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR. 1997. Kaposi’s sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276:1851–1854. http://dx.doi.org/10.1126/science.276.5320.1851.
5. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869. http://dx.doi.org/10.1126/science.7997879.
6. Schulz TF. 1999. Epidemiology of Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8. Adv. Cancer Res. 76:121–160. http://dx.doi.org/10.1016/S0065-230X(08)60775-7.
7. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. 2000. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J. Infect. Dis. 181:1562–1568. http://dx.doi.org/10.1086/315456.
8. Dukers NH, Rezza G. 2003. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS 17:1717–1730. http://dx.doi.org/10.1097/00002030-200308150-00001.
9. Komanduri KV, Luce JA, McGrath MS, Herndier BG, Ng VL. 1996. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13:215–226. http://dx.doi.org/10.1097/00042560-199600001-00032.
10. Polizzotto MN, Uldrick TS, Hu D, Yarchoan R. 2012. Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome. Front. Microbiol. 3:73. http://dx.doi.org/10.3389/fmicb.2012.00073.
11. Schulte KM, Talat N. 2010. Castleman’s disease—a two compartment model of HHV8 infection. Nat. Rev. Clin. Oncol. 7:533–543. http://dx.doi.org/10.1038/nrclinonc.2010.103.
12. Chakraborty S, Veettil MV, Chandran B. 2012. Kaposi’s sarcoma associated herpesvirus entry into target cells. Front. Microbiol. 3:6. http://dx.doi.org/10.3389/fmicb.2012.00006.
13. Chandran B. 2010. Early events in Kaposi’s sarcoma-associated herpesvirus infection of target cells. J. Virol. 84:2188–2199. http://dx.doi.org/10.1128/JVI.01334-09.
14. Bottero V, Chakraborty S, Chandran B. 2012. Reactive oxygen species (ROS) are induced by Kaposi’s sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry. J. Virol. 87:1733–1749. http://dx.doi.org/10.1128/JVI.02958-12.
15. Ballon G, Chen K, Perez R, Tam W, Cesarman E. 2011. Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J. Clin. Invest. 121:1141–1153. http://dx.doi.org/10.1172/JCI44417.
16. Hassman LM, Ellison TJ, Kedes DH. 2011. KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J. Clin. Invest. 121:752–768. http://dx.doi.org/10.1172/JCI44185.
17. Myoung J, Ganem D. 2011. Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4_ T cells. J. Clin. Invest. 121:1130–1140. http://dx.doi.org/10.1172/JCI43755.
18. Myoung J, Ganem D. 2011. Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells. Virology 413:1–11. http://dx.doi.org/10.1016/j.virol.2010.12.036.
19. Lan K, Kuppers DA, Robertson ES. 2005. Kaposi’s sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway. J. Virol. 79:3468–3478. http://dx.doi.org/10.1128/JVI.79.6.3468-3478.2005.
20. Lan K, Kuppers DA, Verma SC, Robertson ES. 2004. Kaposi’s sarcomaassociated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virusmediated control of latency. J. Virol. 78:6585-6594. http://dx.doi.org/10.1128/JVI.78.12.6585-6594.2004.
21. Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES. 2005. Induction of Kaposi’s sarcoma-associated herpesvirus latencyassociated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J. Virol. 79:7453–7465. http://dx.doi.org/10.1128/JVI.79.12.7453-7465.2005.
22. Lu J, Verma SC, Cai Q, Robertson ES. 2011. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi’s sarcomaassociated herpesvirus latency during primary infection. J. Virol. 85: 6148–6161. http://dx.doi.org/10.1128/JVI.02608-10.
23. Lu J, Verma SC, Cai Q, Saha A, Dzeng RK, Robertson ES. 2012. The RBP-Jkappa binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation. PLoS Pathog. 8:e1002479.
24. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33(Suppl):245–254. http://dx.doi.org/10.1038/ng1089.
25. Skinner MK, Manikkam M, Guerrero-Bosagna C. 2010. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol. Metab. 21:214–222. http://dx.doi.org/10.1016/j.tem.2009.12.007.
26. Sharma S, Kelly TK, Jones PA. 2010. Epigenetics in cancer. Carcinogenesis 31:27–36. http://dx.doi.org/10.1093/carcin/bgp220.
27. Esteller M. 2002. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21:5427–5440. http://dx.doi.org/10.1038/sj.onc.1205600.
28. Spivakov M, Fisher AG. 2007. Epigenetic signatures of stem-cell identity. Nat. Rev. Genet. 8:263–271. http://dx.doi.org/10.1038/nrg2046.
29. Esteller M. 2007. Cancer epigenomics: DNA methylomes and histonemodification maps. Nat. Rev. Genet. 8:286–298. http://dx.doi.org/10.1038/nrg2005.
30. Lu F, Stedman W, Yousef M, Renne R, Lieberman PM. 2010. Epigenetic regulation of Kaposi’s sarcoma-associated herpesvirus latency by virusencoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol. 84:2697–2706. http://dx.doi.org/10.1128/JVI.01997-09.
31. He M, Zhang W, Bakken T, Schutten M, Toth Z, Jung JU, Gill P, Cannon M, Gao SJ. 2012. Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2. Cancer Res. 72: 3582–3592. http://dx.doi.org/10.1158/1538-7445.AM2012-3582.
32. Toth Z, Maglinte DT, Lee SH, Lee HR, Wong LY, Brulois KF, Lee S, Buckley JD, Laird PW, Marquez VE, Jung JU. 2010. Epigenetic analysisof KSHV latent and lytic genomes. PLoS Pathog. 6:e1001013. http://dx.doi.org/10.1371/journal.ppat.1001013.
33. Günther T, Grundhoff A. 2010. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6:e1000935. http://dx.doi.org/10.1371/journal.ppat.1000935.
34. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U. S. A. 93:14862–14867. http://dx.doi.org/10.1073/pnas.93.25.14862.
35. Grundhoff A, Ganem D. 2004. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113:124–136. http://dx.doi.org/10.1172/JCI200417803.
36. Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, Chandran B. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi’s sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78:3601–3620. http://dx.doi.org/10.1128/JVI.78.7.3601-3620.2004.
37. Lu F, Tsai K, Chen HS, Wikramasinghe P, Davuluri RV, Showe L, Domsic J, Marmorstein R, Lieberman PM. 2012. Identification of hostchromosome binding sites and candidate gene targets for Kaposi’s sarcoma-associated herpesvirus LANA. J. Virol. 86:5752–5762. http://dx.doi.org/10.1128/JVI.07216-11.
38. Chen J, Ye F, Xie J, Kuhne K, Gao SJ. 2009. Genome-wide identification of binding sites for Kaposi’s sarcoma-associated herpesvirus lytic switch protein, RTA. Virology 386:290–302. http://dx.doi.org/10.1016/j.virol.2009.01.031.
39. González CM, Wong EL, Bowser BS, Hong GK, Kenney S, Damania B. 2006. Identification and characterization of the Orf49 protein of Kaposi’s sarcoma-associated herpesvirus. J. Virol. 80:3062–3070. http://dx.doi.org/10.1128/JVI.80.6.3062-3070.2006.
40. Inn KS, Lee SH, Rathbun JY, Wong LY, Toth Z, Machida K, Ou JH, Jung JU. 2011. Inhibition of RIG-I-mediated signaling by Kaposi’s sarcoma-associated herpesvirus-encoded deubiquitinase ORF64. J. Virol. 85:10899–10904. http://dx.doi.org/10.1128/JVI.00690-11.
41. González CM, Wang L, Damania B. 2009. Kaposi’s sarcoma-associated herpesvirus encodes a viral deubiquitinase. J. Virol. 83:10224–10233. http://dx.doi.org/10.1128/JVI.00589-09.
42. Iqbal K, Jin SG, Pfeifer GP, Szabó PE. 2011. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl. Acad. Sci. U. S. A. 108:3642–3647. http://dx.doi.org/10.1073/pnas.1014033108.
43. Bonvicini F, Manaresi E, Di Furio F, De Falco L, Gallinella G. 2012. Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression. PLoS One 7:e33316. http://dx.doi.org/10.1371/journal.pone.0033316.
44. Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E. 2009. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 5:e1000495. http://dx.doi.org/10.1371/journal.ppat.1000495.
45. Ablashi DV, Chatlynne LG, Whitman JE, Jr, Cesarman E. 2002. Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin. Microbiol. Rev. 15:439–464. http://dx.doi.org/10.1128/CMR.15.3.439-464.2002.
46. Mitra A, Luo J, Zhang H, Cui K, Zhao K, Song J. 2012. Marek’s disease virus infection induces widespread differential chromatin marks in inbred chicken lines. BMC Genomics 13:557. http://dx.doi.org/10.1186/1471-2164-13-557.
47. Queen KJ, Shi M, Zhang F, Cvek U, Scott RS. 2013. Epstein-Barr virus-induced epigenetic alterations following transient infection. Int. J. Cancer 132:2076–2086. http://dx.doi.org/10.1002/ijc.27893.
48. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global changes in Kaposi’s sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 77:4205-4220. http://dx.doi.org/10.1128/JVI.77.7.4205-4220.2003.
49. Dodd RB, Allen MD, Brown SE, Sanderson CM, Duncan LM, Lehner PJ, Bycroft M, Read RJ. 2004. Solution structure of the Kaposi’s sarcomaassociated herpesvirus K3 N-terminal domain reveals a novel E2-binding C4HC3-type RING domain. J. Biol. Chem. 279:53840–53847. http://dx.doi.org/10.1074/jbc.M409662200.
50. Ishido S, Wang C, Lee BS, Cohen GB, Jung JU. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi’s sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74: 5300–5309. http://dx.doi.org/10.1128/JVI.74.11.5300-5309.2000.
51. Olp LN, Shea DM, White MK, Gondwe C, Kankasa C, Wood C. 2013. Early childhood infection of Kaposi’s sarcoma-associated herpesvirus in Zambian households: a molecular analysis. Int. J. Cancer 132:1182–1190. http://dx.doi.org/10.1002/ijc.27729.
52. Rimessi P, Bonaccorsi A, Stürzl M, Fabris M, Brocca-Cofano E, Caputo A, Melucci-Vigo G, Falchi M, Cafaro A, Cassai E, Ensoli B, Monini P. 2001. Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi’s sarcoma. J. Virol. 75: 7161–7174. http://dx.doi.org/10.1128/JVI.75.15.7161-7174.2001.
53. Shamay M, Hand N, Lemas MV, Koon HB, Krown SE, Wrangle J, Desai P, Ramos JC, Ambinder RF. 2012. CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA. J. Infect. Dis. 205: 1095–1099. http://dx.doi.org/10.1093/infdis/jis032.
54. Minhas V, Crabtree KL, Chao A, M’Soka TJ, Kankasa C, Bulterys M, Mitchell CD, Wood C. 2008. Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area. Am. J. Epidemiol. 168:311–320. http://dx.doi.org/10.1093/aje/kwn125.
55. Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, Hettler E, Gao SJ. 2002. Efficient infection by a recombinant Kaposi’s sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J. Virol. 76:6185-6196. http://dx.doi.org/10.1128/JVI.76.12.6185-6196.2002.
56. Lu J, Verma SC, Cai Q, Robertson ES. 2011. The single RBP-Jkappa site within the LANA promoter is crucial for establishing KSHV latency during primary infection. J. Virol. 85:6148–6161. http://dx.doi.org/10.1128/JVI.02608-10.
57. Dollard SC, Butler LM, Jones AM, Mermin JH, Chidzonga M, Chipato T, Shiboski CH, Brander C, Mosam A, Kiepiela P, Hladik W, Martin JN. 2010. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the “KS Belt.” Int. J. Cancer 127:2395–2401. http://dx.doi.org/10.1002/ijc.25235.
58. Jha HC, AJ MP, Saha A, Banerjee S, Lu J, Robertson ES. 2014. Epstein- Barr virus essential antigen EBNA3C attenuates H2AX expression. J. Virol. 88:3776–3788. http://dx.doi.org/10.1128/JVI.03568-13.
59. Jha HC, Lu J, Saha A, Cai Q, Banerjee S, Prasad MA, Robertson ES. 2013. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases. J. Virol. 87:12121–12138. http://dx.doi.org/10.1128/JVI.02379-13.
60. Mitchell N, Deangelis JT, Tollefsbol TO. 2011. Methylated-CpG island recovery assay. Methods Mol. Biol. 791:125–133. http://dx.doi.org/10.1007/978-1-61779-316-5_10.
61. Rauch T, Pfeifer GP. 2005. Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer. Lab. Invest. 85:1172–1180. http://dx.doi.org/10.1038/labinvest.3700311.